Please use this identifier to cite or link to this item:
Title: Economic evaluations of interventional opportunities for the management of mental–physical multimorbidity: a systematic review
Authors: Banstola, A
Pokhrel, S
Hayhoe, B
Nicholls, D
Harris, M
Anokye, N
Issue Date: 28-Feb-2023
Publisher: BMJ Publishing Group
Citation: Banstola A, Pokhrel S, Hayhoe B, et al. (2023). 'Economic evaluations of interventional opportunities for the management of mental–physical multimorbidity: a systematic review' in BMJ Open., Vol.13 (2)., pp.1 - 10.
Abstract: Copyright © Author(s) (or their employer(s)) 2023. Objectives Economic evaluations of interventions for people with mental–physical multimorbidity, including a depressive disorder, are sparse. This study examines whether such interventions in adults are cost-effective. Design A systematic review. Data sources MEDLINE, CINAHL Plus, PsycINFO, Cochrane CENTRAL, Scopus, Web of Science and NHS EED databases were searched until 5 March 2022. Eligibility criteria We included studies involving people aged ≥18 with two or more chronic conditions (one being a depressive disorder). Economic evaluation studies that compared costs and outcomes of interventions were included, and those that assessed only costs or effects were excluded. Data extraction and synthesis Two authors independently assessed risk of bias in included studies using recommended checklists. A narrative analysis of the characteristics and results by type of intervention and levels of healthcare provision was conducted. Results A total of 19 studies, all undertaken in high-income countries, met inclusion criteria. Four intervention types were reported: collaborative care, self-management, telephone-based and antidepressant treatment. Most (14 of 19) interventions were implemented at the organisational level and were potentially cost-effective, particularly, the collaborative care for people with depressive disorder and diabetes, comorbid major depression and cancer and depression and multiple long-term conditions. Cost-effectiveness ranged from £206 per quality-adjusted life year (QALY) for collaborative care programmes for older adults with diabetes and depression at primary care clinics (USA) to £79 723 per QALY for combining collaborative care with improved opportunistic screening for adults with depressive disorder and diabetes (England). Conclusions on cost-effectiveness were constrained by methodological aspects of the included studies: choice of perspectives, time horizon and costing methods. Conclusions Economic evaluations of interventions to manage multimorbidity with a depressive disorder are non-existent in low-income and middle-income countries. The design and reporting of future economic evaluations must improve to provide robust conclusions. PROSPERO registration number CRD42022302036.
Description: Data availability statement: All data relevant to the study are included in the article or uploaded as supplementary information.
Other Identifiers: ORCID iDs: Amrit Banstola; Subhash Pokhrel; Benedict Hayhoe; Dasha Nicholls; Matthew Harris; Nana Anokye
Appears in Collections:Dept of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons